Takeda H
Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1992 Jan;67(1):98-108.
In order to evaluate the role of secretagogue-induced changes of cytosolic free calcium concentration ([Ca2+]i) in pepsinogen release, the effects of cholecystokinin-octapeptide (CCK-8) on pepsinogen release and on [Ca2+]i in gastric chief cells isolated from guinea pig stomach were investigated. [Ca2+]i was measured with fura-2, Ca(2+)-sensitive fluorescent probe, using dual-wavelength excitation fluorospectrophotometer. In the presence of extracellular Ca2+, CCK-8 induced a rapid and transient increase in [Ca2+]i followed by a sustained plateau of [Ca2+]i increase which remained 20-50 nM above basal level until antagonist was added. Both in the absence of external Ca2+ and in the presence of inorganic Ca2+ channel blocker Ni2+(2 nM), plateau phase but not initial transient peak of [Ca2+]i was diminished. On the other hand, nicardipine, an organic Ca2+ channel blocker, did not affect the [Ca2+]i transient induced by CCK-8. Time course of CCK-8-stimulated pepsinogen release was biphasic; the initial phase of pepsinogen release was unaffected by Ca2+ removal from the medium but was inhibited by Ca2+ chelation with an intracellular Ca2+ chelator BAPTA/AM, while the late phase of pepsinogen release was dependent on extracellular Ca2+. Artificially introduced Ca2+ into the chief cells with ionomycin elicited the increase in [Ca2+]i and pepsinogen release. However, ionomycin-induced release of pepsinogen was transient and several times smaller than that induced by CCK-8. Ni(2+)-sensitive Ca2+ influx across the plasma membrane was also necessary for reloading of agonist-sensitive Ca2+ pool. These results suggest that the initial, transient increase in [Ca2+]i from the intracellular Ca2+ store mediates the initial pepsinogen release, while the sustained increase in [Ca2+]i which is dependent on Ca2+ influx is responsible for the late phase of pepsinogen release. Factors other than the changes in [Ca2+]i may also be required in producing optimal pepsinogen release.
为了评估促分泌素诱导的胞质游离钙浓度([Ca2+]i)变化在胃蛋白酶原释放中的作用,研究了八肽胆囊收缩素(CCK-8)对从豚鼠胃中分离出的胃主细胞中胃蛋白酶原释放及[Ca2+]i的影响。使用双波长激发荧光分光光度计,用Ca(2+)敏感荧光探针fura-2测量[Ca2+]i。在细胞外Ca2+存在的情况下,CCK-8诱导[Ca2+]i迅速短暂升高,随后是[Ca2+]i升高的持续平台期,在加入拮抗剂之前一直比基础水平高20 - 50 nM。在无细胞外Ca2+以及存在无机Ca2+通道阻滞剂Ni2+(2 nM)的情况下,[Ca2+]i的平台期但不是初始短暂峰值减小。另一方面,有机Ca2+通道阻滞剂尼卡地平不影响CCK-8诱导的[Ca2+]i瞬变。CCK-8刺激胃蛋白酶原释放的时间过程是双相的;胃蛋白酶原释放的初始阶段不受培养基中Ca2+去除的影响,但受到细胞内Ca2+螯合剂BAPTA/AM的Ca2+螯合作用的抑制,而胃蛋白酶原释放的后期阶段依赖于细胞外Ca2+。用离子霉素将Ca2+人工引入主细胞会引起[Ca2+]i升高和胃蛋白酶原释放。然而,离子霉素诱导的胃蛋白酶原释放是短暂的,且比CCK-8诱导的释放小几倍。跨质膜的Ni(2+)敏感Ca2+内流对于激动剂敏感Ca2+池的重新装载也是必需的。这些结果表明,来自细胞内Ca2+储存的[Ca2+]i的初始短暂升高介导了胃蛋白酶原的初始释放,而依赖于Ca2+内流的[Ca2+]i的持续升高则负责胃蛋白酶原释放的后期阶段。在产生最佳胃蛋白酶原释放时,可能还需要[Ca2+]i变化以外的其他因素。